Sign In
Last checked at 
16 Oct 2023 07:00
LEI: 549300Q7EXQQH6KF7Z84
16 October 2023
RTW Biotech Opportunities Ltd (the "Company")
Transaction in Own Shares
The Company announces that on 13 October 2023 it bought back 500,000 of its own shares, to be held as treasury shares, at an average price of $1.1 per share.
Further details are set out below:
Number of shares held as treasury shares following this purchase: 1,250,000
Total shares in issue excluding treasury shares following this purchase: 211,139,138
The Company has bought back these shares under the authority granted by shareholders at its Annual General Meeting in June 2023, which permits the Company to repurchase a maximum of 14.99% of its ordinary shares. The actual number of shares repurchased by the Company will depend on market conditions. This authority lasts until the next shareholder authority granted (expected to be at the Annual General Meeting in 2024), or until expressly revoked by shareholders.
The above figure 211,139,138 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
No maximum consideration payable has been determined by the Company, but the Company is unable to pay a price for any shares pursuant to the buyback which would equate to a premium to the net asset value. It is the Company's current intention to hold any shares bought back in treasury.
The Company has instructed Numis Securities Limited as its broker in respect of its buyback transactions. This arrangement is in accordance with the UKLA Listing Rules and the Company's general authority to repurchase shares.
For Further Information:
RTW Investments, LP | +44 (0)20 7959 6361 |
Woody Stileman, Managing Director Krisha McCune, Director, Client Service |
|
|
|
Follow the stocks
